BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 25252084)

  • 1. Insight to the thermodynamic stability of molecular crystals through crystallographic studies of a multipolymorph system.
    Ng AT; Lai C; Dabros M; Gao Q
    J Pharm Sci; 2014 Nov; 103(11):3423-3431. PubMed ID: 25252084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achieving polymorph selectivity in the crystallization of pharmaceutical solids: basic considerations and recent advances.
    Reutzel-Edens SM
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):806-15. PubMed ID: 17117688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dapsone Form V: A Late Appearing Thermodynamic Polymorph of a Pharmaceutical.
    Braun DE; Vickers M; Griesser UJ
    Mol Pharm; 2019 Jul; 16(7):3221-3236. PubMed ID: 31075201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The computational prediction of pharmaceutical crystal structures and polymorphism.
    Price SL
    Adv Drug Deliv Rev; 2004 Feb; 56(3):301-19. PubMed ID: 14962583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The integration of solid-form informatics into solid-form selection.
    Feeder N; Pidcock E; Reilly AM; Sadiq G; Doherty CL; Back KR; Meenan P; Docherty R
    J Pharm Pharmacol; 2015 Jun; 67(6):857-68. PubMed ID: 25891945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermodynamic relationships between nateglinide polymorphs.
    Bruni G; Berbenni V; Milanese C; Girella A; Cardini A; Viganò E; Lanfranconi S; Marini A
    J Pharm Biomed Anal; 2009 Dec; 50(5):764-70. PubMed ID: 19570642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-state supramolecular synthesis based on the N-H…O heterosynthon: an approach to solve the polymorphism problem in famotidine.
    Russo MG; Brusau EV; Ellena J; Narda GE
    J Pharm Sci; 2014 Nov; 103(11):3754-3763. PubMed ID: 25277273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QTAIM application in drug development: prediction of relative stability of drug polymorphs from experimental crystal structures.
    Abramov YA
    J Phys Chem A; 2011 Nov; 115(45):12809-17. PubMed ID: 21939257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational polymorphism in organic crystals.
    Nangia A
    Acc Chem Res; 2008 May; 41(5):595-604. PubMed ID: 18348538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The polymorphism of progesterone: stabilization of a 'disappearing' polymorph by co-crystallization.
    Lancaster RW; Karamertzanis PG; Hulme AT; Tocher DA; Lewis TC; Price SL
    J Pharm Sci; 2007 Dec; 96(12):3419-31. PubMed ID: 17621678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphic forms of lupane triterpenoid betulonic aldehyde (betulonal).
    Chrobak E; Michalik E; Kusz J; Nowak M; Boryczka S
    Acta Crystallogr C Struct Chem; 2014 Sep; 70(Pt 9):847-51. PubMed ID: 25186355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallization force--a density functional theory concept for revealing intermolecular interactions and molecular packing in organic crystals.
    Li T; Ayers PW; Liu S; Swadley MJ; Aubrey-Medendorp C
    Chemistry; 2009; 15(2):361-71. PubMed ID: 19034948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of known crystals to design polymorph prediction strategies.
    Young PH; Ando HY
    J Pharm Sci; 2007 May; 96(5):1203-36. PubMed ID: 17455343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new high-pressure benzocaine polymorph - towards understanding the molecular aggregation in crystals of an important active pharmaceutical ingredient (API).
    Patyk-Kaźmierczak E; Kaźmierczak M
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2020 Feb; 76(Pt 1):56-64. PubMed ID: 32831241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
    Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
    Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorph farming of acetaminophen and sulfathiazole on a chip.
    Lee T; Hung ST; Kuo CS
    Pharm Res; 2006 Nov; 23(11):2542-55. PubMed ID: 16969701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism in 3-acetyl-4-hydroxy-2H-chromen-2-one.
    Ghouili A; Brahmia A; Ben Hassen R
    Acta Crystallogr C Struct Chem; 2015 Oct; 71(Pt 10):873-7. PubMed ID: 26422214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorph selection: the role of nucleation, crystal growth and molecular modeling.
    Erdemir D; Lee AY; Myerson AS
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):746-55. PubMed ID: 17987526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular packing and intermolecular interactions in two structural polymorphs of N-palmitoylethanolamine, a type 2 cannabinoid receptor agonist.
    Kamlekar RK; Swamy MJ
    J Lipid Res; 2006 Jul; 47(7):1424-33. PubMed ID: 16609146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphs and polymorphic cocrystals of temozolomide.
    Babu NJ; Reddy LS; Aitipamula S; Nangia A
    Chem Asian J; 2008 Jul; 3(7):1122-33. PubMed ID: 18512823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.